{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:08Z","timestamp":1792783508205,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yunnan Provincial Reserve Project for Young and Middle-aged Academic and Technical Leaders","award":["202205AC160046"],"award-info":[{"award-number":["202205AC160046"]}]},{"name":"Kunming Medical University Graduate Student Innovation Fund","award":["2025S204"],"award-info":[{"award-number":["2025S204"]}],"id":[{"id":"https:\/\/ror.org\/038c3w259","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yunnan Province Science and Technology Special Project","award":["202601AT070110"],"award-info":[{"award-number":["202601AT070110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01452-7","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:57:34Z","timestamp":1789592254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LOXL4: a key regulatory factor at the intersection of fibrosis and tumor progression"],"prefix":"10.1007","volume":"39","author":[{"given":"Yan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"1452_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9133-4_1","volume":"1952","author":"D Manou","year":"2019","unstructured":"Manou D, Caon I, Bouris P, et al. The complex interplay between extracellular matrix and cells in tissues. Methods Mol Biol. 2019;1952:1\u201320.","journal-title":"Methods Mol Biol"},{"key":"1452_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/9783110258776.3","volume-title":"Extracellular matrix: pathobiology and signaling","author":"AD Theocharis","year":"2012","unstructured":"Theocharis AD, Gialeli C, Hascall VC, et al. Extracellular matrix: a functional scaffold. In: Karamanos NK, editor., et al., Extracellular matrix: pathobiology and signaling. Berlin\/Boston: Walter de Gruyter GmbH & Co. KG; 2012. p. 3\u201320."},{"key":"1452_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.matbio.2017.10.004","volume":"75\u201376","author":"E Mavrogonatou","year":"2019","unstructured":"Mavrogonatou E, Pratsinis H, Papadopoulou A, et al. Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis. Matrix Biol. 2019;75\u201376:27\u201342.","journal-title":"Matrix Biol"},{"key":"1452_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2019.11.005","volume":"85\u201386","author":"M Urbanczyk","year":"2020","unstructured":"Urbanczyk M, Layland SL, Schenke-Layland K. The role of extracellular matrix in biomechanics and its impact on bioengineering of cells and 3D tissues. Matrix Biol. 2020;85\u201386:1\u201314.","journal-title":"Matrix Biol"},{"issue":"15","key":"1452_CR5","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1111\/febs.14992","volume":"286","author":"NK Karamanos","year":"2019","unstructured":"Karamanos NK. Extracellular matrix: key structural and functional meshwork in health and disease. FEBS J. 2019;286(15):2826\u20139.","journal-title":"FEBS J"},{"issue":"15","key":"1452_CR6","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1111\/febs.14818","volume":"286","author":"AD Theocharis","year":"2019","unstructured":"Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a multitasking player in disease. FEBS J. 2019;286(15):2830\u201369.","journal-title":"FEBS J"},{"issue":"24","key":"1452_CR7","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1111\/febs.15776","volume":"288","author":"NK Karamanos","year":"2021","unstructured":"Karamanos NK, Theocharis AD, Piperigkou Z, et al. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021;288(24):6850\u2013912.","journal-title":"FEBS J"},{"issue":"3","key":"1452_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1165\/ajrcmb\/5.3.206","volume":"5","author":"HM Kagan","year":"1991","unstructured":"Kagan HM, Trackman PC. Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol. 1991;5(3):206\u201310.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"1452_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/abio.2001.5464","volume":"300","author":"AH Palamakumbura","year":"2002","unstructured":"Palamakumbura AH, Trackman PC. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem. 2002;300(2):245\u201351.","journal-title":"Anal Biochem"},{"issue":"4","key":"1452_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jcb.10413","volume":"88","author":"HM Kagan","year":"2003","unstructured":"Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003;88(4):660\u201372.","journal-title":"J Cell Biochem"},{"issue":"6","key":"1452_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/jcb.21371","volume":"101","author":"SL Payne","year":"2007","unstructured":"Payne SL, Hendrix MJ, Kirschmann DA. Paradoxical roles for lysyl oxidases in cancer\u2014a prospect. J Cell Biochem. 2007;101(6):1338\u201354.","journal-title":"J Cell Biochem"},{"issue":"19-20","key":"1452_CR12","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00018-006-6149-9","volume":"63","author":"HA Lucero","year":"2006","unstructured":"Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006;63(19\u201320):2304\u201316.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1452_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0014-4827(87)90343-0","volume":"173","author":"E Butler","year":"1987","unstructured":"Butler E, Hardin J, Benson S. The role of lysyl oxidase and collagen crosslinking during sea urchin development. Exp Cell Res. 1987;173(1):174\u201382.","journal-title":"Exp Cell Res"},{"issue":"24","key":"1452_CR14","doi-asserted-by":"publisher","first-page":"22977","DOI":"10.1074\/jbc.M503006200","volume":"280","author":"J Molnar","year":"2005","unstructured":"Molnar J, Ujfaludi Z, Fong SF, et al. Drosophila lysyl oxidases Dmloxl-1 and Dmloxl-2 are differentially expressed and the active DmLOXL-1 influences gene expression and development. J Biol Chem. 2005;280(24):22977\u201385.","journal-title":"J Biol Chem"},{"issue":"1","key":"1452_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1039\/B613673G","volume":"3","author":"C Anderson","year":"2007","unstructured":"Anderson C, Bartlett SJ, Gansner JM, et al. Chemical genetics suggests a critical role for lysyl oxidase in zebrafish notochord morphogenesis. Mol Biosyst. 2007;3(1):51\u20139.","journal-title":"Mol Biosyst"},{"issue":"8","key":"1452_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1432-0436.2005.00041.x","volume":"73","author":"TJ Geach","year":"2005","unstructured":"Geach TJ, Dale L. Members of the lysyl oxidase family are expressed during the development of the frog Xenopus laevis. Differentiation. 2005;73(8):414\u201324.","journal-title":"Differentiation"},{"issue":"1","key":"1452_CR17","first-page":"167","volume":"82","author":"ML Casey","year":"1997","unstructured":"Casey ML, MacDonald PC. Lysyl oxidase (ras recision gene) expression in human amnion: ontogeny and cellular localization. J Clin Endocrinol Metab. 1997;82(1):167\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1452_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/plac.2000.0580","volume":"22","author":"S Hein","year":"2001","unstructured":"Hein S, Yamamoto SY, Okazaki K, et al. Lysyl oxidases: expression in the fetal membranes and placenta. Placenta. 2001;22(1):49\u201357.","journal-title":"Placenta"},{"issue":"4","key":"1452_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3892\/or_00000502","volume":"22","author":"Y Kim","year":"2009","unstructured":"Kim Y, Roh S, Park JY, et al. Differential expression of the LOX family genes in human colorectal adenocarcinomas. Oncol Rep. 2009;22(4):799\u2013804.","journal-title":"Oncol Rep"},{"issue":"8","key":"1452_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3319","volume":"12","author":"HE Barker","year":"2012","unstructured":"Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer. 2012;12(8):540\u201352.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1452_CR21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00726-023-03343-9","volume":"55","author":"J Wang","year":"2023","unstructured":"Wang J, Chen C, Huang J, et al. The possibilities of LOXL4 as a prognostic marker for carcinomas. Amino Acids. 2023;55(11):1519\u201329.","journal-title":"Amino Acids"},{"issue":"4","key":"1452_CR22","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.21037\/tcr-23-2003","volume":"13","author":"R Liu","year":"2024","unstructured":"Liu R, Li B, Zi J, et al. The dual role of LOXL4 in the pathogenesis and development of human malignant tumors: a narrative review. Transl Cancer Res. 2024;13(4):2026\u201342.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1452_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10585-012-9514-0","volume":"30","author":"S Sebban","year":"2013","unstructured":"Sebban S, Golan-Gerstl R, Karni R, et al. Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer. Clin Exp Metastasis. 2013;30(1):103\u201317.","journal-title":"Clin Exp Metastasis"},{"issue":"Suppl 1","key":"1452_CR24","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/IJG.0000000000000910","volume":"27","author":"F Rodriguez-Pascual","year":"2018","unstructured":"Rodriguez-Pascual F, Rosell-Garcia T. Lysyl oxidases: functions and disorders. J Glaucoma. 2018;27(Suppl 1):S15\u20139.","journal-title":"J Glaucoma"},{"issue":"7","key":"1452_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0945-053X(01)00161-5","volume":"20","author":"L Asuncion","year":"2001","unstructured":"Asuncion L, Fogelgren B, Fong KS, et al. A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain. Matrix Biol. 2001;20(7):487\u201391.","journal-title":"Matrix Biol"},{"issue":"1","key":"1452_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.v24.i1.10","volume":"24","author":"MR Sarrias","year":"2004","unstructured":"Sarrias MR, Gr\u00f8nlund J, Padilla O, et al. The scavenger receptor cysteine-rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol. 2004;24(1):1\u201337.","journal-title":"Crit Rev Immunol"},{"issue":"5","key":"1452_CR27","first-page":"2683","volume":"11","author":"Z Du","year":"2019","unstructured":"Du Z, Xia Q, Wu B, et al. The analyses of SRCR genes based on protein-protein interaction network in esophageal squamous cell carcinoma. Am J Transl Res. 2019;11(5):2683\u2013705.","journal-title":"Am J Transl Res"},{"issue":"2-4","key":"1452_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.imbio.2005.05.010","volume":"210","author":"BO Fabriek","year":"2005","unstructured":"Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology. 2005;210(2\u20134):153\u201360.","journal-title":"Immunobiology"},{"issue":"31","key":"1452_CR29","doi-asserted-by":"publisher","first-page":"18187","DOI":"10.1074\/jbc.270.31.18187","volume":"270","author":"GS Whitney","year":"1995","unstructured":"Whitney GS, Starling GC, Bowen MA, et al. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J Biol Chem. 1995;270(31):18187\u201390.","journal-title":"J Biol Chem"},{"issue":"8","key":"1452_CR30","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.str.2015.05.019","volume":"23","author":"PE Chappell","year":"2015","unstructured":"Chappell PE, Garner LI, Yan J, et al. Structures of CD6 and its ligand CD166 give insight into their interaction. Structure (Lond). 2015;23(8):1426\u201336.","journal-title":"Structure (Lond)"},{"issue":"12","key":"1452_CR31","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1128\/MCB.00036-13","volume":"33","author":"O Busnadiego","year":"2013","unstructured":"Busnadiego O, Gonz\u00e1lez-Santamar\u00eda J, Lagares D, et al. LOXL4 is induced by transforming growth factor \u03b21 through Smad and JunB\/Fra2 and contributes to vascular matrix remodeling. Mol Cell Biol. 2013;33(12):2388\u2013401.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"1452_CR32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.molmed.2012.08.001","volume":"18","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Molecular mechanisms mediating metastasis of hypoxic breast cancer cells. Trends Mol Med. 2012;18(9):534\u201343.","journal-title":"Trends Mol Med"},{"issue":"5","key":"1452_CR33","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-10-1516","volume":"71","author":"F Pez","year":"2011","unstructured":"Pez F, Dayan F, Durivault J, et al. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 2011;71(5):1647\u201357.","journal-title":"Cancer Res"},{"issue":"7","key":"1452_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00109-011-0855-y","volume":"90","author":"CCL Wong","year":"2012","unstructured":"Wong CCL, Zhang H, Gilkes DM, et al. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J Mol Med (Berl). 2012;90(7):803\u201315.","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"1452_CR35","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/mc.22686","volume":"56","author":"Z Wei","year":"2017","unstructured":"Wei Z, Shan Y, Tao L, et al. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1\u03b1 synthesis, and decreases breast cancer metastasis. Mol Carcinog. 2017;56(10):2317\u201331.","journal-title":"Mol Carcinog"},{"issue":"10","key":"1452_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/dna.2016.3342","volume":"35","author":"XD Xia","year":"2016","unstructured":"Xia XD, Lee J, Khan S, et al. Suppression of phosphatidylinositol 3-kinase\/Akt signaling attenuates hypoxia-induced pulmonary hypertension through the downregulation of lysyl oxidase. DNA Cell Biol. 2016;35(10):599\u2013606.","journal-title":"DNA Cell Biol"},{"issue":"9","key":"1452_CR37","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-07-0012","volume":"67","author":"G Wu","year":"2007","unstructured":"Wu G, Guo Z, Chang X, et al. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras\/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 2007;67(9):4123\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"1452_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3\u201311.","journal-title":"Semin Liver Dis"},{"issue":"4","key":"1452_CR39","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.21037\/jtd-23-329","volume":"15","author":"J Chen","year":"2023","unstructured":"Chen J, Zhou D, Liao H, et al. MiR-183-5p regulates ECM and EMT to promote non-small cell lung cancer progression by targeting LOXL4. J Thorac Dis. 2023;15(4):1734\u201348.","journal-title":"J Thorac Dis"},{"issue":"7","key":"1452_CR40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/15384101.2021.2016197","volume":"21","author":"P Ren","year":"2022","unstructured":"Ren P, Niu X, Zhao R, et al. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p\/LOXL4 axis in laryngeal squamous cell carcinoma. Cell Cycle. 2022;21(7):697\u2013707.","journal-title":"Cell Cycle"},{"key":"1452_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-234","volume":"13","author":"H Deng","year":"2014","unstructured":"Deng H, Lv L, Li Y, et al. MiR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway. Mol Cancer. 2014;13:234.","journal-title":"Mol Cancer"},{"issue":"19","key":"1452_CR42","doi-asserted-by":"publisher","first-page":"8494","DOI":"10.7150\/thno.44849","volume":"10","author":"H Yin","year":"2020","unstructured":"Yin H, Wang Y, Wu Y, et al. EZH2-mediated epigenetic silencing of miR-29\/miR-30 targets LOXL4 and contributes to tumorigenesis, metastasis, and immune microenvironment remodeling in breast cancer. Theranostics. 2020;10(19):8494\u2013512.","journal-title":"Theranostics"},{"issue":"13","key":"1452_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310985","volume":"24","author":"C A\u00f1azco","year":"2023","unstructured":"A\u00f1azco C, Riedelsberger J, Vega-Montoto L, et al. Exploring the interplay between polyphenols and lysyl oxidase enzymes for maintaining extracellular matrix homeostasis. Int J Mol Sci. 2023;24(13):10985.","journal-title":"Int J Mol Sci"},{"key":"1452_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.matbio.2016.01.001","volume":"52\u201354","author":"PC Trackman","year":"2016","unstructured":"Trackman PC. Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone. Matrix Biol. 2016;52\u201354:7\u201318.","journal-title":"Matrix Biol"},{"issue":"5","key":"1452_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891\u2013906.","journal-title":"Cell"},{"issue":"21","key":"1452_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf0133","volume":"9","author":"HY Ma","year":"2023","unstructured":"Ma HY, Li Q, Wong WR, et al. LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung. Sci Adv. 2023;9(21):eadf0133.","journal-title":"Sci Adv"},{"key":"1452_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1142907","volume":"13","author":"NLGY Komalasari","year":"2023","unstructured":"Komalasari NLGY, Tomonobu N, Kinoshita R, et al. Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2. Front Oncol. 2023;13:1142907.","journal-title":"Front Oncol"},{"key":"1452_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1371307","volume":"14","author":"F Jiang","year":"2024","unstructured":"Jiang F, Chen Y, Tomonobu N, et al. Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-\u03b21-NF-\u03baB-MMP9 axis. Front Oncol. 2024;14:1371307.","journal-title":"Front Oncol"},{"key":"1452_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1371342","volume":"14","author":"T Takahashi","year":"2024","unstructured":"Takahashi T, Tomonobu N, Kinoshita R, et al. Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface. Front Oncol. 2024;14:1371342.","journal-title":"Front Oncol"},{"issue":"1","key":"1452_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010071","volume":"13","author":"SD Vallet","year":"2020","unstructured":"Vallet SD, Berthollier C, Salza R, et al. The interactome of cancer-related lysyl oxidase and lysyl oxidase-like proteins. Cancers (Basel). 2020;13(1):71.","journal-title":"Cancers (Basel)"},{"issue":"19","key":"1452_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911378","volume":"23","author":"S Zaffryar-Eilot","year":"2022","unstructured":"Zaffryar-Eilot S, Hasson P. Lysyl oxidases: orchestrators of cellular behavior and ECM remodeling and homeostasis. Int J Mol Sci. 2022;23(19):11378.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1452_CR52","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/s41418-019-0293-x","volume":"26","author":"J Shao","year":"2019","unstructured":"Shao J, Lu J, Zhu W, et al. Derepression of LOXL4 inhibits liver cancer growth by reactivating compromised p53. Cell Death Differ. 2019;26(11):2237\u201352.","journal-title":"Cell Death Differ"},{"issue":"2","key":"1452_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.31236","volume":"72","author":"W Chen","year":"2020","unstructured":"Chen W, Yang A, Jia J, et al. Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis. Hepatology. 2020;72(2):729\u201341.","journal-title":"Hepatology"},{"issue":"4","key":"1452_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41374-018-0159-8","volume":"99","author":"M Huang","year":"2019","unstructured":"Huang M, Liu Z, Baugh L, et al. Lysyl oxidase enzymes mediate TGF-\u03b21-induced fibrotic phenotypes in human skin-like tissues. Lab Invest. 2019;99(4):514\u201327.","journal-title":"Lab Invest"},{"issue":"5","key":"1452_CR55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/art.41163","volume":"72","author":"M Huang","year":"2020","unstructured":"Huang M, Cai G, Baugh LM, et al. Systemic sclerosis dermal fibroblasts induce cutaneous fibrosis through lysyl oxidase-like 4: new evidence from three-dimensional skin-like tissues. Arthritis Rheumatol. 2020;72(5):791\u2013801.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1452_CR56","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/hep.31600","volume":"73","author":"HY Tan","year":"2021","unstructured":"Tan HY, Wang N, Zhang C, et al. Lysyl oxidase-like 4 fosters an immunosuppressive microenvironment during hepatocarcinogenesis. Hepatology. 2021;73(6):2326\u201341.","journal-title":"Hepatology"},{"issue":"1","key":"1452_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0948-8","volume":"18","author":"R Li","year":"2019","unstructured":"Li R, Wang Y, Zhang X, et al. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis. Mol Cancer. 2019;18(1):18.","journal-title":"Mol Cancer"},{"issue":"7","key":"1452_CR58","doi-asserted-by":"publisher","first-page":"11977","DOI":"10.18632\/oncotarget.14450","volume":"8","author":"SK Choi","year":"2017","unstructured":"Choi SK, Kim HS, Jin T, et al. LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer. Oncotarget. 2017;8(7):11977\u201389.","journal-title":"Oncotarget"},{"issue":"8","key":"1452_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9080097","volume":"9","author":"WK You","year":"2017","unstructured":"You WK, Stallcup WB. Localization of VEGF to vascular ECM is an important aspect of tumor angiogenesis. Cancers (Basel). 2017;9(8):97.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1452_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10456-021-09804-7","volume":"25","author":"M Bao","year":"2022","unstructured":"Bao M, Chen Y, Liu JT, et al. Extracellular matrix stiffness controls VEGF165 secretion and neuroblastoma angiogenesis via the YAP\/RUNX2\/SRSF1 axis. Angiogenesis. 2022;25(1):71\u201386.","journal-title":"Angiogenesis"},{"issue":"1","key":"1452_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ijos.2013.96","volume":"6","author":"WP Jiang","year":"2014","unstructured":"Jiang WP, Sima ZH, Wang HC, et al. Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis. Int J Oral Sci. 2014;6(1):31\u20138.","journal-title":"Int J Oral Sci"},{"issue":"4","key":"1452_CR62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2008.06.071","volume":"373","author":"DJ Kim","year":"2008","unstructured":"Kim DJ, Lee DC, Yang SJ, et al. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC\/PRF\/5 hepatoma cells. Biochem Biophys Res Commun. 2008;373(4):521\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1452_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188356","volume":"1873","author":"B Piersma","year":"2020","unstructured":"Piersma B, Hayward MK, Weaver VM. Fibrosis and cancer: a strained relationship. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188356.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"1452_CR64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180802","volume":"135","author":"YM Yang","year":"2025","unstructured":"Yang YM, Kim J, Wang Z, et al. Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment. J Clin Invest. 2025;135(7):e180802.","journal-title":"J Clin Invest"},{"issue":"5","key":"1452_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051294","volume":"19","author":"L Caja","year":"2018","unstructured":"Caja L, Dituri F, Mancarella S, et al. TGF-\u03b2 and the tissue microenvironment: relevance in fibrosis and cancer. Int J Mol Sci. 2018;19(5):1294.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1452_CR66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ymthe.2022.09.012","volume":"31","author":"X Liu","year":"2023","unstructured":"Liu X, Zhou J, Wu H, et al. Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma. Mol Ther. 2023;31(1):119\u201333.","journal-title":"Mol Ther"},{"issue":"1","key":"1452_CR67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14(1):54.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"1452_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, et al. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15(5):307.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1452_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030491","volume":"13","author":"YFI Setargew","year":"2021","unstructured":"Setargew YFI, Wyllie K, Grant RD, et al. Targeting lysyl oxidase family meditated matrix cross-linking as an anti-stromal therapy in solid tumours. Cancers (Basel). 2021;13(3):491.","journal-title":"Cancers (Basel)"},{"key":"1452_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113998","volume":"385","author":"Y Wu","year":"2025","unstructured":"Wu Y, Chen W, Deng J, et al. Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment. J Control Release. 2025;385:113998.","journal-title":"J Control Release"},{"issue":"1","key":"1452_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37811","volume":"113","author":"MAK Tolentino","year":"2025","unstructured":"Tolentino MAK, Seyedzadeh MH, Peres NG, et al. Polyethylene glycol-based hydrogel as a 3D extracellular matrix mimic for cytotoxic T lymphocytes. J Biomed Mater Res A. 2025;113(1):e37811.","journal-title":"J Biomed Mater Res A"},{"key":"1452_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.58688","volume":"10","author":"A Nicolas-Boluda","year":"2021","unstructured":"Nicolas-Boluda A, Vaquero J, Vimeux L, et al. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. Elife. 2021;10:e58688.","journal-title":"Elife"},{"issue":"13","key":"1452_CR73","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","volume":"187","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li J, Hou Y, et al. Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor. Cell. 2024;187(13):3409-3426.e24.","journal-title":"Cell"},{"issue":"4","key":"1452_CR74","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94(4):1287\u2013312.","journal-title":"Physiol Rev"},{"issue":"1","key":"1452_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000591","volume":"18","author":"E Stampouloglou","year":"2020","unstructured":"Stampouloglou E, Cheng N, Federico A, et al. Yap suppresses T-cell function and infiltration in the tumor microenvironment. PLoS Biol. 2020;18(1):e3000591.","journal-title":"PLoS Biol"},{"key":"1452_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.904418","volume":"13","author":"H Gao","year":"2022","unstructured":"Gao H, Tian Q, Zhou Y, et al. 3D collagen fiber concentration regulates Treg cell infiltration in triple negative breast cancer. Front Immunol. 2022;13:904418.","journal-title":"Front Immunol"},{"issue":"1","key":"1452_CR77","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12964-025-02380-z","volume":"23","author":"WB Huang","year":"2025","unstructured":"Huang WB, Lai HZ, Long J, et al. Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets. Cell Commun Signal. 2025;23(1):375.","journal-title":"Cell Commun Signal"},{"key":"1452_CR78","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.actbio.2022.04.031","volume":"163","author":"PV Taufalele","year":"2023","unstructured":"Taufalele PV, Wang W, Simmons AJ, et al. Matrix stiffness enhances cancer-macrophage interactions and M2-like macrophage accumulation in the breast tumor microenvironment. Acta Biomater. 2023;163:365\u201377.","journal-title":"Acta Biomater"},{"issue":"1","key":"1452_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04810-3","volume":"22","author":"J Xiong","year":"2024","unstructured":"Xiong J, Xiao R, Zhao J, et al. Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. J Transl Med. 2024;22(1):85.","journal-title":"J Transl Med"},{"issue":"20","key":"1452_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012270","volume":"23","author":"W Wang","year":"2022","unstructured":"Wang W, Wang X, Yao F, et al. Lysyl oxidase family proteins: prospective therapeutic targets in cancer. Int J Mol Sci. 2022;23(20):12270.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1452_CR81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","volume":"5","author":"G Raghu","year":"2017","unstructured":"Raghu G, Brown KK, Collard HR, et al. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. Lancet Respir Med. 2017;5(1):22\u201332.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"1452_CR82","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","volume":"155","author":"SA Harrison","year":"2018","unstructured":"Harrison SA, Abdelmalek MF, Caldwell S, et al. Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis. Gastroenterology. 2018;155(4):1140\u201353.","journal-title":"Gastroenterology"},{"issue":"2","key":"1452_CR83","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hep.30237","volume":"69","author":"AJ Muir","year":"2019","unstructured":"Muir AJ, Levy C, Janssen HLA, et al. Simtuzumab for primary sclerosing cholangitis: phase 2 study results with insights on the natural history of the disease. Hepatology. 2019;69(2):684\u201398.","journal-title":"Hepatology"},{"issue":"3","key":"1452_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1634\/theoncologist.2017-0024","volume":"22","author":"AB Benson 3rd","year":"2017","unstructured":"Benson AB 3rd, Wainberg ZA, Hecht JR, et al. A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma. Oncologist. 2017;22(3):241-e15.","journal-title":"Oncologist"},{"key":"1452_CR85","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.289108","author":"RF Schlenk","year":"2026","unstructured":"Schlenk RF, Harrison CN, Palandri F, et al. GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study. Haematologica. 2026. https:\/\/doi.org\/10.3324\/haematol.2025.289108.","journal-title":"Haematologica"},{"issue":"10","key":"1452_CR86","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3324\/haematol.2024.287231","volume":"110","author":"P Vachhani","year":"2025","unstructured":"Vachhani P, Tan P, Watson AM, et al. A phase I\/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis. Haematologica. 2025;110(10):2376\u201387.","journal-title":"Haematologica"},{"issue":"D1","key":"1452_CR87","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53(D1):D1670\u20136.","journal-title":"Nucleic Acids Res"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01452-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:02:46Z","timestamp":1789596166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01452-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":87,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01452-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"141"}}